| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/06/1997 | EP0787299A1 Receptor for a bacillus thuringiensis toxin |
| 08/06/1997 | EP0787211A1 Method for identifying protective antigens for eliciting neutralizing antibodies |
| 08/06/1997 | EP0787191A2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 08/06/1997 | EP0787190A2 Hepatitis e virus antigens and uses therefor |
| 08/06/1997 | EP0787187A1 Her4 human receptor tyrosine kinase |
| 08/06/1997 | EP0787185A2 Targeted hetero-association of recombinant proteins to multi-functional complexes |
| 08/06/1997 | EP0787181A1 Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof |
| 08/06/1997 | EP0787151A1 Monoclonal antibody fragments having immunosuppressant activity |
| 08/06/1997 | EP0787149A1 POLYNUCLEOTIDE ENCODING C5a RECEPTOR |
| 08/06/1997 | EP0787148A1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 08/06/1997 | EP0787145A1 Novel tnf receptor death domain ligand proteins and inhibitors of ligand binding |
| 08/06/1997 | EP0787144A1 Major outer membrane protein cd of moraxella |
| 08/06/1997 | EP0787142A1 Neurturin and related growth factors |
| 08/06/1997 | EP0787136A1 Novel opacity associated proteins, dna encoding the same, and methods of use thereof |
| 08/06/1997 | EP0787014A1 Use of flea proteases and protease inhibitors to protect animals from flea infestation |
| 08/06/1997 | EP0787013A1 Human hypoxanthine-(guanine) phosphoribosyl transferase-2 |
| 08/06/1997 | EP0677107B1 Clotting inhibitor made from protostomia saliva |
| 08/06/1997 | EP0548070B1 Monoclonal antibody for differentiation of squamous cell carcinoma antigens and method of use for same |
| 08/06/1997 | EP0502845B1 Human high-affinity neurotransmitter uptake system |
| 08/06/1997 | EP0368857B1 Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms |
| 08/06/1997 | CN1156481A Extraction of heterologous insoluble proteins from bacteria |
| 08/06/1997 | CN1156460A Reconstructed hyman antibody against human interleukin-8 |
| 08/06/1997 | CN1156459A Trefoil peptide dimer |
| 08/05/1997 | US5654407 Human anti-TNF antibodies |
| 08/05/1997 | US5654405 Detection and purification of kgf; treating excessive epithelial cell growth; skin disorders, e.g., psoriasis; antitumor and carcinogenic agents |
| 08/05/1997 | US5654403 Immunoglobulins stabilized with a chelator of copper ions |
| 08/05/1997 | US5654271 Fungicidally active compounds |
| 08/05/1997 | US5654188 Human dna; genetic engineering |
| 08/05/1997 | US5654184 Mixing with food transgenic plant which comprises and expresses dna sequence coding for antigen or antigenic determinant of pathogenic microorganism capable of eliciting immune response on oral administration |
| 08/05/1997 | US5654160 Imine- and mercaptan-containing aryl ligands; quantitative analysis; immunoassay; detecting metal concentrations in blood samples |
| 08/05/1997 | US5654158 Methods for detection of nephropathy-related immunoglobulin G using monoclonal antibodies specific for nephropathy-related immunoglobulin G |
| 08/05/1997 | US5654157 Genetic engineering |
| 08/05/1997 | US5654150 Method of expression cloning |
| 08/05/1997 | US5654146 Human ice homolog |
| 08/05/1997 | US5654145 Trophinin and trophinin-assisting nucleic acids and methods of detection thereof |
| 08/05/1997 | US5654139 Isolated dna sequence coding for allelic variation of serotonin 5-ht2c receptor having serine at position 23 instead of cysteine |
| 08/05/1997 | US5654138 Von hippel-lindau (VHL) disease gene and corresponding cDNA and methods for detecting carriers of the VHL disease gene |
| 08/05/1997 | US5653984 Extract of periwinkle seed and compositions containing the same |
| 08/05/1997 | US5653975 Implanting encapsulated cells capable of producing human growth factor or trophic factor for diffusion into the central nervous system; treatment of diabetes; anemia; hypoparathyroidism; parkinson's and alzheimer's disease |
| 08/05/1997 | CA2008824C Method for the production of glucagon |
| 08/05/1997 | CA1339210C Recombinant techniques for production of novel natriuretic and vasodilator peptides |
| 08/05/1997 | CA1339209C Site selective genomic modification of yeast of the genus pichia |
| 08/05/1997 | CA1339208C Fusion proteins containing a hinge region for enhanced cleavage |
| 08/05/1997 | CA1339204C Mucin core polypeptide, antibodies and probes |
| 08/05/1997 | CA1339202C Method for preparing monoclonal antibody to hepatitis b surface antigen |
| 08/05/1997 | CA1339201C Chimera monoclonal antibody and a production process thereof |
| 08/05/1997 | CA1339199C Magnetic protein conjugates, a process for the preparation thereof, and the use thereof |
| 08/05/1997 | CA1339198C Antibodies to the antigen campath-1 |
| 08/05/1997 | CA1339193C Human rhinovirus receptor protein that inhibits virus infectivity |
| 07/31/1997 | WO1997027485A1 Method for detecting anti-gadii antibody and method for diagnosing cancer using said detection method |
| 07/31/1997 | WO1997027319A1 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| 07/31/1997 | WO1997027313A1 Cold-active protease cp70 |
| 07/31/1997 | WO1997027305A1 Production of bacillus thuringiensis integrants |
| 07/31/1997 | WO1997027300A1 TOXOPLASMA GONDII ANTIGEN Tg20 |
| 07/31/1997 | WO1997027296A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
| 07/31/1997 | WO1997027218A1 Method for evaluating and affecting male fertility |
| 07/31/1997 | WO1997027208A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 07/31/1997 | WO1997026916A1 Obesity protein analog compounds and formulations thereof |
| 07/31/1997 | WO1997026907A1 Novel administration of thrombopoietin |
| 07/31/1997 | WO1997026853A2 Dna encoding galanin galr2 receptors and uses thereof |
| 07/31/1997 | CA2244373A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 07/31/1997 | CA2242417A1 Novel administration of thrombopoietin |
| 07/31/1997 | CA2242200A1 Toxoplasma gondii antigen tg20 |
| 07/31/1997 | CA2216227A1 Dna encoding galanin galr2 receptors and uses thereof |
| 07/30/1997 | EP0786521A1 Nucleic acid encoding PspA |
| 07/30/1997 | EP0786520A1 Method for the production of biological active beta-NGF by genetic engineering |
| 07/30/1997 | EP0786519A2 Staphylococcus aureus polynucleotides and sequences |
| 07/30/1997 | EP0786474A1 A recombinant buman factor VIII derivative |
| 07/30/1997 | EP0786472A1 Vaccines and diagnostic assays for Haemophilus influenzae |
| 07/30/1997 | EP0786084A1 Method for screening compositions |
| 07/30/1997 | EP0786009A1 Process for bacterial production of heterologous polypeptides with disulphide bonds |
| 07/30/1997 | EP0786007A1 Transgenic nonhuman animal having functionally disrupted interleukin-1-beta converting enzyme gene |
| 07/30/1997 | EP0786004A1 Cloning, expression and characterisation of a novel form of phosphatidylinositol-3-kinase |
| 07/30/1997 | EP0786003A1 Insect viruses and their uses in protecting plants |
| 07/30/1997 | EP0786000A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 07/30/1997 | EP0785999A1 Plant transcription regulators from circovirus |
| 07/30/1997 | EP0785993A1 Monoclonal antibodies to thymidine kinase isozymes |
| 07/30/1997 | EP0785990A1 Method for stimulating profileration of colon cells using pomc 76-103 |
| 07/30/1997 | EP0785988A1 Method of synthesizing saccharide compositions |
| 07/30/1997 | EP0785950A2 Keratinocyte growth factor analogs |
| 07/30/1997 | EP0785949A1 Method for purifying keratinocyte growth factors |
| 07/30/1997 | EP0785948A1 Analogs of keratinocyte growth factor |
| 07/30/1997 | EP0785946A1 Materials for the production of nanometer structures and use thereof |
| 07/30/1997 | EP0785799A1 Process for production of inhibited forms of activated blood factors |
| 07/30/1997 | EP0785716A1 Cytokine designated lerk-6 |
| 07/30/1997 | EP0604495B1 Secondary-metabolite biosynthesis genes from actinomycetes, method of isolating them, and their use |
| 07/30/1997 | EP0505500B1 Endogenous gene expression modification with regulatory element by way of homologous recombination |
| 07/30/1997 | EP0481089B1 Human monoclonal antibody against glycoprotein gp iii of varicella zoster virus |
| 07/30/1997 | CN1155931A Preparation of derivatized 10,10'-substituted-9,9'-biacridine luminescent molecules and signal solutions |
| 07/30/1997 | CN1155904A LAG-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 07/30/1997 | CN1155548A £Beta-9 glutamic acid, beta-10 aspartic acid| human insulin |
| 07/29/1997 | US5652353 DNAs encoding tumor necrosis factor-α muteins |
| 07/29/1997 | US5652352 Afamin: a human serum albumin-like gene |
| 07/29/1997 | US5652338 Neutrophil chemotactic factor |
| 07/29/1997 | US5652333 gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies |
| 07/29/1997 | US5652223 DNA encoding CAI resistance proteins and uses thereof |
| 07/29/1997 | US5652217 Nucleotide sequence from staphylococcus aureus which codes for protein or polypeptide |
| 07/29/1997 | US5652210 Soluble splice variant of the Fas (APO-1) antigen, FasΔTM |
| 07/29/1997 | US5652138 Immunoreacts with human immunodeficiency virus glycoprotein |
| 07/29/1997 | US5652131 Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and methods |